Kinase domain point mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia emerge after therapy with BCR-ABL kinase inhibitors

Dan Jones, Deborah Thomas, C. Cameron Yin, Susan O'Brien, Jorge E. Cortes, Elias Jabbour, Megan Breeden, Francis J. Giles, Weiqiang Zhao, Hagop M. Kantarjian

Research output: Contribution to journalArticlepeer-review

95 Scopus citations

Fingerprint Dive into the research topics of 'Kinase domain point mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia emerge after therapy with BCR-ABL kinase inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences